The sleep apnea devices market is broadly categorized into four major segments based on the product type such as actigraphy systems, polysomnography (PSG) devices, respiratory polygraphs, and single-channel screening devices pulse oximeters. The actigraphy systems segment is growing rapidly in the sleep apnea devices industry with substantial revenue generation in the last few years. The growing popularity of the actigraphy systems segment is attributed to the cost-effectiveness and easy availability of the product.
Download Free Sample - https://www.millioninsights.com/industry-reports/sleep-apnea-devices-market/request-sample
The sleep apnea devices market is divided by region as North America, Europe, Asia-Pacific, Latin America, and Africa. North America has shown major growth in recent years owing to the rise in the implementation of the latest technologies in the healthcare sector, surge in the number of research & development activities in the region, and existence of well-established medical infrastructure.
Asia-Pacific region is estimated to hold a major market share in sleep apnea devices with massive growth in the forecast period. Countries such as India, China, and Singapore are leading the Asia-Pacific market with strong economic growth, increasing healthcare expenditure, rising disposable income, growing awareness level among the general population, and significant investment by leading industry players considering potential growth opportunities in the region. The key players in the sleep apnea devices industry are BMC Medical Co., Ltd., GE Healthcare, Inc., Fisher & Paykel Healthcare Ltd., Curative Medical, Inc., Cadwell Laboratories, Inc., ResMed Co., Invacare Corp., Braebon Medical Corp., ImThera Medical, Inc., Phillips Respironics N.V., Curative Medical Inc., Nihon Kohden Co., and Compumedics Ltd.
No comments:
Post a Comment